TGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Faherty, Noel ^a   O'Donovan, Helen ^a   Kavanagh, David ^a,d   Madden, Stephen ^c   McKay, Gareth J ^d   Maxwell, Alexander P ^d   Martin, Finian ^a   Godson, Catherine ^b   Crean, John ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c DUBLIN CITY UNIVERSITY   (Ireland)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Actin; CREB; CTGF CCN2; E2F1; TGF beta

Indexed keywords

ACTIN RELATED PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN CDC42; TRANSCRIPTION FACTOR E2F1; TRANSFORMING GROWTH FACTOR BETA;

ACTIN FILAMENT; ACTIN RELATED GENE; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOSKELETON; DIABETIC NEPHROPATHY; EMBRYO; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; HUMAN; HUMAN CELL; HYPERTROPHY; MOLECULAR PATHOLOGY; REGULATOR GENE;

ACTINS; BINDING SITES; CDC42 GTP-BINDING PROTEIN; CELL LINE; CELL MOVEMENT; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIABETIC NEPHROPATHIES; E2F1 TRANSCRIPTION FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; HYPERTROPHY; MESANGIAL CELLS; PROTEIN BINDING; PROTEIN INTERACTION MAPS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

EID: 84880862232     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-525     Document Type: Article

References (43)

1. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008, 14(9):931-938. 10.1038/nm.1857, 18724379.
2. Gallagher AR, Cedzich A, Gretz N, Somlo S, Witzgall R. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci USA 2000, 97(8):4017-4022. 10.1073/pnas.97.8.4017, 18134, 10760273.
3. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000, 24(3):251-256. 10.1038/73456, 10700177.
4. Sutton TA, Molitoris BA. Mechanisms of cellular injury in ischemic acute renal failure. Semin Nephrol 1998, 18(5):490-497.
5. Crean JK, Finlay D, Murphy M, Moss C, Godson C, Martin F, Brady HR. The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem 2002, 277(46):44187-44194. 10.1074/jbc.M203715200, 12218048.
6. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999, 274(9):5830-5834. 10.1074/jbc.274.9.5830, 10026205.
7. Cortes P, Riser BL, Yee J, Narins RG. Mechanical strain of glomerular mesangial cells in the pathogenesis of glomerulosclerosis: clinical implications. articlet 1999, 14(6):1351-1354.
8. Etienne-Manneville S. Actin and microtubules in cell motility: which one is in control?. Traffic 2004, 5(7):470-477. 10.1111/j.1600-0854.2004.00196.x, 15180824.
9. Defilippi P, Olivo C, Venturino M, Dolce L, Silengo L, Tarone G. Actin cytoskeleton organization in response to integrin-mediated adhesion. Microsc Res Tech 1999, 47(1):67-78. 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.0.CO;2-P, 10506763.
10. Delon I, Brown NH. Integrins and the actin cytoskeleton. Curr Opin Cell Biol 2007, 19(1):43-50. 10.1016/j.ceb.2006.12.013, 17184985.
11. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279(5350):509-514. 10.1126/science.279.5350.509, 9438836.
12. Faherty N, Curran SP, O'Donovan H, Martin F, Godson C, Brazil DP, Crean JK. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFbeta type II receptor with implications for nephropathic cell phenotypes. J Cell Sci 2012, 125(Pt 23):5621-5629.
13. O'Donovan HC, Hickey F, Brazil DP, Kavanagh DH, Oliver N, Martin F, Godson C, Crean J. Connective tissue growth factor antagonizes transforming growth factor-beta1/Smad signalling in renal mesangial cells. Biochem J 2012, 441(1):499-510. 10.1042/BJ20110910, 21871016.
14. Nguyen TQ, Roestenberg P, van Nieuwenhoven FA, Bovenschen N, Li Z, Xu L, Oliver N, Aten J, Joles JA, Vial C, et al. CTGF inhibits BMP-7 signaling in diabetic nephropathy. JASN 2008, 19(11):2098-2107. 10.1681/ASN.2007111261, 2573007, 18632843.
15. Ito Y, Goldschmeding R, Kasuga H, Claessen N, Nakayama M, Yuzawa Y, Sawai A, Matsuo S, Weening JJ, Aten J. Expression patterns of connective tissue growth factor and of TGF-beta isoforms during glomerular injury recapitulate glomerulogenesis. Am J Physiol Renal Physiol 2010, 299(3):F545-F558. 10.1152/ajprenal.00120.2009, 20576680.
16. Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley TW, Brenner M, Guo G, Zhang W, Oliver N, et al. Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease. Fibrogenesis & tissue repair 2011, 4(1):4. 10.1186/1755-1536-4-4, 23975892.
17. Blom IE, van Dijk AJ, Wieten L, Duran K, Ito Y, Kleij L, DeNichilo M, Rabelink TJ, Weening JJ, Aten J, et al. In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant 2001, 16(6):1139-1148. 10.1093/ndt/16.6.1139, 11390712.
18. Crean JK, Furlong F, Finlay D, Mitchell D, Murphy M, Conway B, Brady HR, Godson C, Martin F. Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization. FASEB 2004, 18(13):1541-1543.
19. Furlong F, Crean J, Thornton L, O'Leary R, Murphy M, Martin F. Dysregulated intracellular signaling impairs CTGF-stimulated responses in human mesangial cells exposed to high extracellular glucose. Am J Physiol Renal Physiol 2007, 292(6):F1691-F1700. 10.1152/ajprenal.00342.2006, 17327498.
20. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990, 86(2):453-462. 10.1172/JCI114731, 296747, 2200803.
21. Sharma K, Ziyadeh F. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 1994, 267:F1094-F1101.
22. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA. Expression of transforming growth factor beta isoforms in human glomerular diseases. Kidney Int 1996, 49:461-469. 10.1038/ki.1996.65, 8821830.
23. Adler SG, Kang SW, Feld S, Cha DR, Barba L, Striker L, Striker GE, Riser BL, LaPage T, Nast CC. Glomerular mRNAs in human type I diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephoprathy. Kidney Int 2001, 60:2330-2336. 10.1046/j.1523-1755.2001.00073.x, 11737607.
24. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998, 53(4):853-861. 10.1111/j.1523-1755.1998.00820.x, 9551391.
25. Riser BL, Cortes P. Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis. Ren Fail 2001, 23(3-4):459-470.
26. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000, 11(1):25-38.
27. Twigg SM, Cao Z, McLennan SV, Burns WC, Brammar G, Forbes JM, Cooper ME. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 2002, 143:4907-4915. 10.1210/en.2002-220619, 12446618.
28. Wahab NA, Yevdokimova N, Weston BS, Roberts T, Li XJ, Brinkman H, Mason RM. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 2001, 316:985-992.
29. Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, Aten J, Hoppener JW, Goldschmeding R. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN2) in diabetic nephropathy. Am J Physiol Renal Physiol 2006, 290:F1344-F1354. 10.1152/ajprenal.00174.2005, 16380465.
30. Yokoi H, Mukoyama M, Mori K, Kasahara M, Suganami T, Sawai K, Yoshioka T, Saito Y, Ogawa Y, Kuwabara T, et al. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int 2008, 73:446-455. 10.1038/sj.ki.5002722, 18075496.
31. Lee HS. Paracrine role for TGF-beta-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease. Histol Histopathol 2012, 27(9):1131-1141.
32. Umezono T, Toyoda M, Kato M, Miyauchi M, Kimura M, Maruyama M, Honma M, Yagame M, Suzuki D. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy. J Nephrol 2006, 19(6):751-757.
33. Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia 2005, 48(12):2650-2660. 10.1007/s00125-005-0006-5, 16270194.
34. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987, 165(1):251-256. 10.1084/jem.165.1.251, 2188256, 3491869.
35. Johannessen M, Delghandi MP, Moens U. What turns CREB on?. Cell Signal 2004, 16(11):1211-1227. 10.1016/j.cellsig.2004.05.001, 15337521.
36. Gruden G, Perin PC, Camussi G. Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Curr Diabetes Rev 2005, 1(1):27-40. 10.2174/1573399052952622, 18220580.
37. Thomas MC, Burns WC, Cooper ME. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 2005, 12(2):177-186. 10.1053/j.ackd.2005.01.008, 15822053.
38. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nat Geosci 2002, 420(6916):629-635.
39. Itoh RE, Kurokawa K, Ohba Y, Yoshizaki H, Mochizuki N, Matsuda M. Activation of rac and cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells. Mol Cell Biol 2002, 22(18):6582-6591. 10.1128/MCB.22.18.6582-6591.2002, 135619, 12192056.
40. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nat Geosci 2001, 414(6862):457-462.
41. Ruster C, Bondeva T, Franke S, Forster M, Wolf G. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes. Nephrol Dial Transplant 2008, 23(7):2179-2191. 10.1093/ndt/gfn085, 18344241.
42. Klemm DJ, Watson PA, Frid MG, Dempsey EC, Schaack J, Colton LA, Nesterova A, Stenmark KR, Reusch JE. cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration. J Biol Chem 2001, 276(49):46132-46141. 10.1074/jbc.M104769200, 11560924.
43. Jeffery IB, Madden SF, McGettigan PA, Perriere G, Culhane AC, Higgins DG. Integrating transcription factor binding site information with gene expression datasets. Bioinformatics 2007, 23(3):298-305. 10.1093/bioinformatics/btl597, 17127681.